September 2022 – Addis Ababa, Ethiopia
VIDEO
Meeting Objectives
Share experiences and lessons learned
Discuss evidence-based policies and program implementation in and across countries
Contribute to the research agenda to accelerate progress in HPV vaccine introduction, access, program optimization, restoration, and sustainability
Discuss new developments in the field and health models that can be integrated with HPV vaccination programs
Provide updated information on available data on HPV vaccine evaluation including schedules
Discuss integration of HPV vaccination programs with adolescent health services.
Saturday, 24th September 2022
SESSION 1: INAUGURAL SESSION
Welcome Note
Honorable State Minister of Health Ethiopia
HE Dr Dereje Duguma
Welcome & Introduction
CHIC SPC Secretariat
Dr. Alex Vorsters, Dr. Nelly Mugo, Dr. Margaret Stanley (online)
Co-host- FMOH Ethiopia
Dr. Meseret Zelalem, Mr. Yohannes Lakew, Mr. Mengistu Bogale
Co-host – Ethiopia Society of Gynaecology and Obstetrics (ESOG)
Dr. Abdulfetah Abdulkadir (President ESOG)
Participants Introduction
SESSION 2: CERVICAL CANCER PREVENTION LANDSCAPE
HPV related cancers incidence, mortality, social and economic impact in Africa
Ms. Ann Korir (KEMRI, ACRN)
HPV vaccination programs – regional overview
Dr. Phionah Atuhebwe (WHO)
SESSION 3: ENSURING EFFECTIVE INTRODUCTIONS: EXPERIENCES AND LESSONS LEARNED FROM DECISION-MAKING, PLANNING, AND PREPARATION OF HPV VACCINATION PROGRAMS
SESSION 3A: LOCAL DATA AVAILABILITY: DENOMINATOR DATA, DATA FOR PLANNING AND STRENGTHENING HEALTH INFORMATION SYSTEMS
Ethiopia Immunization Monitoring System
Mr. Yohannes Lakew (EPI, MOH Ethiopia)
Rwanda data availability: Denominator data, data for planning and strengthening health information systems
Ms. Irene Mukanyandwi (EPI, MOH Rwanda) – Online
Tracking, and follow-up – Lessons learned from other vaccination programs
Mr. Kebba Touray & Ms. Marie Babona Nshuti (WHO)
SESSION 3B: EXPERIENCES AND LESSONS LEARNED FROM DECISION-MAKING, PLANNING, AND PREPARATION OF HPV VACCINATION PROGRAMS
Timely preparedness assessment, associated challenges, and impact on planning
Ms. Temwa Stella Mzengeza (Malawi Ministry of Health)
Importance of stakeholder inclusion and coordination in the planning and introduction of the HPV vaccination program in Côte d’Ivoire / Importance de l’inclusion et de la coordination des parties prenantes dans la planification et l’introduction du programme de vaccination contre le HPV en Côte d’Ivoire
Dr. Innocent Massenon (Chargé de prestation à la Direction de Coordination du Programme Elargi de Vaccination)
SESSION 3C: GAVI APPLICATION PROCESS: PROCESS, BOTTLE NECKS AND LESSONS LEARNED
Mozambique’s Experience with the Introduction of the HPV Vaccine
Ms. Amelia Dipuve (EPI, MOH Mozambique)
GAVI application process, challenges and lessons learned
Dr. Landry Kaucley (EPI Manager, Benin)
SESSION 3D: PANEL DISCUSSION ON TIMELY PLANNING AND THE IMPORTANCE OF IMPROVING PARTNERSHIPS
HPV Vaccination Program Introduction Challenges; An overview from National Stakeholders
Dur-e-Nayab Waheed (University of Antwerp) & Dominique Guillaume (John Hopkins University School of Nursing, Jhpiego)
Planning framework, human resource, and stakeholders’ inclusion/ Timely planning and improving partnerships
Panelists: Dr. Furaha Kyesi (EPI, MOH, Tanzania), Colline Chigodo (EPI Zimbabwe), Dr. Francis Dien Mwansa (MOH Zambia) Lucy Kiari (JSI), Dr. Driwale Alfred (EPI, Uganda), Ms Temwa Mzengeza (EPI, Malawi), Chris Morgan (Jhpiego)
SESSION 4A: PROGRAMMATIC CONSIDERATION – DOSING SCHEDULES: GUIDELINES, NEW STRATEGIES, AND FUTURE APPROACHES
Efficacy of single-dose HPV vaccination among young African women (KEN SHE)
Dr. Maricianah Onono (Kenya)
One dose trial data
Dr. Deborah Watson-Jones (Tanzania) – Online
One dose: current guidelines, available vaccines and opportunities for MAC catchup programs with one dose
Dr. Hiroki Akaba (WHO)
One dose decision making in Nigeria – A progress toward successful HPV Introduction and accelerating coverage in Nigeria
Dr. Garba Bakunawa (NHPCDA, Nigeria)
SESSION 4B: PROGRAMMATIC CONSIDERATIONS: DELIVERY PLATFORMS AND NEW STRATEGIES, AND FUTURE APPROACHES
The Gambia HPV Vaccine Delivery; current delivery strategy and plans for restoring coverage following Covid-19 interruption
Ms. Mamanding Kinteh (EPI Focal person, The Gambia)
HPV Vaccine Delivery Zambia
Mr. Eric Chisupa (EPI Zambia)
HPV Vaccine delivery strategies Kenya
Ms. Christine Miano (EPI, Kenya)
HPV Vaccine Delivery – Liberia
Dr. Adolphus Clark (EPI Manager, Liberia)
Discussion on delivery strategies: Are school based programs sustainable? How HPV vaccine delivery platforms can be made sustainable?
Introduction during Covid-19: implications and strategies to tackle interruptions. The case of Cameroon
Dr. Andreas Njoh Ateke (EPI, Cameroon)
See Day 2 – 25 September 2022
